1. Home
  2. PCT vs CLDX Comparison

PCT vs CLDX Comparison

Compare PCT & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCT
  • CLDX
  • Stock Information
  • Founded
  • PCT 2015
  • CLDX N/A
  • Country
  • PCT United States
  • CLDX United States
  • Employees
  • PCT N/A
  • CLDX N/A
  • Industry
  • PCT Environmental Services
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • PCT Utilities
  • CLDX Health Care
  • Exchange
  • PCT Nasdaq
  • CLDX Nasdaq
  • Market Cap
  • PCT 1.1B
  • CLDX 1.2B
  • IPO Year
  • PCT N/A
  • CLDX 2008
  • Fundamental
  • Price
  • PCT $5.99
  • CLDX $18.30
  • Analyst Decision
  • PCT Strong Buy
  • CLDX Buy
  • Analyst Count
  • PCT 4
  • CLDX 8
  • Target Price
  • PCT $12.50
  • CLDX $54.29
  • AVG Volume (30 Days)
  • PCT 2.6M
  • CLDX 935.8K
  • Earning Date
  • PCT 05-06-2025
  • CLDX 05-05-2025
  • Dividend Yield
  • PCT N/A
  • CLDX N/A
  • EPS Growth
  • PCT N/A
  • CLDX N/A
  • EPS
  • PCT N/A
  • CLDX N/A
  • Revenue
  • PCT N/A
  • CLDX $7,020,000.00
  • Revenue This Year
  • PCT N/A
  • CLDX N/A
  • Revenue Next Year
  • PCT $26.46
  • CLDX N/A
  • P/E Ratio
  • PCT N/A
  • CLDX N/A
  • Revenue Growth
  • PCT N/A
  • CLDX 1.99
  • 52 Week Low
  • PCT $4.50
  • CLDX $14.40
  • 52 Week High
  • PCT $15.58
  • CLDX $47.00
  • Technical
  • Relative Strength Index (RSI)
  • PCT 38.86
  • CLDX 49.59
  • Support Level
  • PCT $5.90
  • CLDX $17.45
  • Resistance Level
  • PCT $6.66
  • CLDX $18.53
  • Average True Range (ATR)
  • PCT 0.71
  • CLDX 1.37
  • MACD
  • PCT 0.02
  • CLDX 0.29
  • Stochastic Oscillator
  • PCT 29.14
  • CLDX 71.69

About PCT PureCycle Technologies Inc. Common stock

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: